Epigenetic Disorder
14
2
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
Self-harm Behaviour Among the Most At-risk Adolescents
Exploratory Study of Rectal Mucus for Diagnosing Disease
Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá
PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)
Effects of Tildrakizumab on Epigenetic Age
Human Sperm Epigenetics in Embryonic Development.
Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and Twins
Nutritional Intervention-induced Weight Loss During the Oncological Treatment of Obesity-related Breast Cancer
Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).
Exercise on microRNA in Osteoarthritis
Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation
Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma
Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment
Epigenetics Modifications in Morbid Obesity and Obstructive Sleep Apnea Patients: The EPIMOOSA Study